Pyrilutamide
Pyrilutamide (developmental code name KX-826) is a nonsteroidal antiandrogen (NSAA) which is under development for the treatment of androgenic alopecia (pattern hair loss) and acne. The drug is being developed by Suzhou Kintor Pharmaceuticals.